KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at the University of Cambridge.
Publications:
Immunopharmacology 1982, 5(2) 123–7
Brit J Haematology 1980, 44, 415–424
Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. We have partnered with ECACC (The European Collection of Cell Cultures; a Public Health England Culture Collection) to manage distribution of the majority of these cells on our behalf. Enquires to either organisation are welcomed.
Make an Enquiry
